COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center


Purpose of Study

Investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic aortic stenosis at intermediate surgical risk by randomizing patients to either surgical aortic valve replacement (SAVR) or TAVI with the Medtronic Core Valve System

Trial Status

In follow up

Eligibility Criteria

Severe aortic stenosis, Heart Team unanimously agree, STS risk score >4% and < 10%

Duration of Participation

Approximately 5-10 years

Contact Name: Kendra Tuttle, RN

Contact Phone: 515-235-5102

Contact Email: